Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMontanaro Uk Regulatory News (MTU)

Share Price Information for Montanaro Uk (MTU)

Share Price is delayed by 15 minutes
Get Live Data
109.00    0.50 (0.46%)
Bid:
108.00
Ask:
109.00
Spread: 1.00 (0.926%)
Market Cap: £121.84m
MTU Live PriceLast checked at - London Stock Exchange

Intraday Montanaro Uk Share Chart

Update from QuotedData

29 Apr 2025 09:49

RNS Number : 6156G
Montanaro UK Smlr Cos Inv Tst PLC
29 April 2025
 

Montanaro UK Smaller Companies - Update from QuotedData

29th April 2025

High growth, bigger yield

Montanaro UK Smaller Companies (MTU) has adopted a new enhanced dividend policy, paying out 1.5% of net asset value (NAV) every quarter. This will make it one of the highest-yielding UK equity strategies on the market. For traditional equity income investors, whose portfolios tend to be tilted towards more value-focused cash-generative stocks, MTU's combination of a high dividend yield and a strong focus on quality growth stocks differentiates it from peers.

UK equities were cheap relative to their history and to developed market peers prior to the tariff-related sell off; now they are even cheaper. In addition, the quality-growth small-cap stocks in which MTU invests have been out of vogue recently, with the market favouring large-cap value stocks instead.

As MTU's manager Charles Montanaro points out, the historic valuation gap provides investors with an attractive entry point. History has shown that buying stocks on these sorts of valuations can produce attractive long-term returns, and the magnitude of the discount of the UK's equity market relative to other developed global equity markets could in itself be a catalyst for the UK market to rerate.

Full Research:

https://quoteddata.com/research/montanaro-uk-smaller-companies-high-growth-bigger-yield-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Montanaro UK Smaller Companies Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPKCBQFBKKOQB
Date   Source Headline
13th Mar 202511:17 amRNSNet Asset Value(s)
12th Mar 202510:58 amRNSNet Asset Value(s)
11th Mar 202511:08 amRNSNet Asset Value(s)
10th Mar 20255:18 pmRNSTransaction in Own Shares
10th Mar 202511:47 amRNSNet Asset Value(s)
7th Mar 20255:14 pmRNSTransaction in Own Shares
7th Mar 20253:30 pmRNSPublication of Circular and General Meeting
7th Mar 20252:36 pmRNSHolding(s) in Company
7th Mar 202512:01 pmRNSNet Asset Value(s)
6th Mar 20255:27 pmRNSTransaction in Own Shares
6th Mar 20253:36 pmRNSHolding(s) in Company
6th Mar 20253:22 pmRNSHolding(s) in Company
6th Mar 202512:41 pmRNSNet Asset Value(s)
5th Mar 20255:11 pmRNSTransaction in Own Shares
5th Mar 20251:12 pmRNSHolding(s) in Company
5th Mar 202512:34 pmRNSNet Asset Value(s)
4th Mar 20255:25 pmRNSTransaction in Own Shares
4th Mar 20251:00 pmRNSNet Asset Value(s)
3rd Mar 20255:18 pmRNSTransaction in Own Shares
3rd Mar 20251:15 pmRNSNet Asset Value(s)
3rd Mar 202511:02 amRNSTotal Voting Rights
28th Feb 202511:27 amRNSNet Asset Value(s)
27th Feb 202511:38 amRNSNet Asset Value(s)
26th Feb 202511:20 amRNSNet Asset Value(s)
25th Feb 20255:27 pmRNSTransaction in Own Shares
25th Feb 202511:01 amRNSNet Asset Value(s)
25th Feb 20257:00 amRNSDiscount Control
24th Feb 20255:24 pmRNSTransaction in Own Shares
24th Feb 202512:18 pmRNSNet Asset Value(s)
21st Feb 20255:35 pmRNSTransaction in Own Shares
21st Feb 202511:39 amRNSNet Asset Value(s)
20th Feb 20255:07 pmRNSTransaction in Own Shares
20th Feb 202511:55 amRNSNet Asset Value(s)
19th Feb 20255:25 pmRNSTransaction in Own Shares
19th Feb 202512:08 pmRNSNet Asset Value(s)
18th Feb 202512:32 pmRNSNet Asset Value(s)
17th Feb 202511:57 amRNSNet Asset Value(s)
17th Feb 20259:28 amRNSDirector/PDMR Shareholding
14th Feb 20255:35 pmRNSTransaction in Own Shares
14th Feb 202512:46 pmRNSNet Asset Value(s)
13th Feb 202511:46 amRNSNet Asset Value(s)
12th Feb 20253:47 pmRNSDirector/PDMR Shareholding
12th Feb 202512:12 pmRNSNet Asset Value(s)
11th Feb 20255:33 pmRNSTransaction in Own Shares
11th Feb 202512:00 pmRNSNet Asset Value(s)
10th Feb 20255:25 pmRNSTransaction in Own Shares
10th Feb 202512:27 pmRNSNet Asset Value(s)
7th Feb 20255:23 pmRNSTransaction in Own Shares
7th Feb 202512:12 pmRNSNet Asset Value(s)
6th Feb 20255:36 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.